Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran
EMHJ-Eastern Mediterranean Health Journal. 2006; 12 (5): 548-554
en Inglés
| IMEMR
| ID: emr-156910
ABSTRACT
We examined the therapeutic effects of albendazole compared to metronidazole in 120 patients with giardiasis in Hamdan. Patients were randomized to receive albendazole [400 mg, once daily for 5 days] or metronidazole [250 mg, 3 times a day for 5 days]. Demographic data of the patients, results of stool for Giardia trophozoites before and after treatment, and drug side- effects were recorded. After treatment 6 [10.0%] of the albendazole group had trophozoites compared with 14 [23.3%] of metronidazole group [P < 0.05]. Patients in the albendazole group had fewer side- effects while 43.3% of the metronidazole group experienced a metallic taste and 35.0% experienced loss of appetite. Albendazole is an easy, safe and effective treatment for giardiasis
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Albendazol
/
Heces
/
Metronidazol
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Adolescente
/
Adulto
/
Niño
/
Child, preschool
/
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
East Mediterr Health J.
Año:
2006
Similares
MEDLINE
...
LILACS
LIS